Medscape Medical NewsAll articles

Volta AF-Xplorer

Volta Medical • Cardiovascular • 09/27/2023

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The Volta AF-Xplorer is an advanced cardiac mapping system that utilizes machine and deep learning algorithms to assist operators in the real-time identification and annotation of spatiotemporal dispersion in intra-cardiac atrial electrograms during atrial fibrillation or tachycardia. While it provides sophisticated analysis of 3D anatomical and electrical maps, its direct clinical significance for guiding catheter ablation therapies for these arrhythmias remains to be established through further clinical investigation.

Summary

The Volta AF-Xplorer is a medical device designed to assist clinicians in evaluating cardiac arrhythmias, specifically atrial fibrillation and atrial tachycardia. It employs machine learning and deep learning algorithms to analyze multipolar intra-cardiac atrial electrograms in real-time, identifying areas exhibiting spatiotemporal dispersion. The system integrates with existing electrophysiology catheters and data acquisition systems, including EP recording systems (via analog communication) and the EnSite X 3D mapping system (via bidirectional digital communication). It consists of a computing platform and software, presenting its analysis graphically on a display located outside the sterile field, allowing for either manual or automatic annotation of 3D anatomical and electrical maps of the human atria. The device processes intra-cardiac signals and, in digital mode, 3D electrode locations to output the presence or absence of electrogram dispersion, cycle length estimations, and tag regions of interest on 3D maps. Key functionalities include the real-time cueing of operators to dispersed electrograms and the generation of color-coded symbols to indicate these areas. While the Volta AF-Xplorer provides advanced mapping capabilities by highlighting electrograms with spatiotemporal dispersion, the document explicitly states that the clinical significance of using this information for guiding catheter ablation of atrial arrhythmias has not yet been established through clinical investigations. The AF-Xplorer builds upon previous iterations by combining specific pre-processing from VX1 and post-processing features from VX1+.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Atrial FibrillationSpatiotemporal DispersionIntra-cardiac Electrograms3D Cardiac MappingMachine LearningDeep LearningElectrophysiologyReal-time AnnotationAtrial TachycardiaElectrogram Analysis

Device Metadata

Submission Number
K232616
Company
Volta Medical
Panel
Cardiovascular
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. What specific features or patterns in intra-cardiac atrial electrograms does the Volta AF-Xplorer's machine learning algorithm identify as 'spatiotemporal dispersion,' and how is this definition quantitatively validated?; Given that its clinical significance for catheter ablation is not established, what are the current primary research or investigational applications for identifying areas with spatiotemporal dispersion using the Volta AF-Xplorer?; How does the performance (e.g., sensitivity, specificity, processing speed) of the automatic annotation feature using bidirectional digital communication with the EnSite X system compare to manual annotation or analog system integration?; What is the typical learning curve for an electrophysiologist to effectively integrate the Volta AF-Xplorer's real-time feedback and annotations into their existing workflow for diagnosing atrial arrhythmias?; Are there any ongoing or planned clinical investigations designed to establish the clinical significance of targeting areas with spatiotemporal dispersion (identified by Volta AF-Xplorer) for improving outcomes in atrial fibrillation ablation procedures?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, deep learning, algorithm, annotation)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Volta AF-Xplorer - Volta Medical | ESL FDA AI Device Intelligence